© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
May 10, 2021 09:47pm
The FDA said vaccinating adolescents is another step in getting the country back to prepandemic life.
May 10, 2021 09:00pm
May 10, 2021 08:43pm
May 10, 2021 07:15pm
May 10, 2021 05:56pm
The American College of Cardiology's 70th Annual Scientific Session & Expo will be held virtually May 15-17, 2021. ACC.21 will provide practice-changing research and cutting-edge education.
ATS 2021 will be held virtually May 14-19, 2021. The meeting will include latest advances and discoveries in respiratory science, patient care and global respiratory health.
If 2020 was dominated by the news of how COVID-19 spread across the globe, then 2021 has so far been focused on ending the pandemic through vaccine distribution.
We interview experts on investigational treatments such as liso-cel, and ask how to bring them to community practice.
The American Journal of Accountable Care® features research and commentary on new payment models.
May 08, 2021
BK virus–specific T cells from healthy donors were an effective and safe off-the-shelf treatment for patients with leukemia or lymphoma who developed a painful and common complication after allogeneic hematopoietic stem cell transplantation.
Biomarkers are being used in patients with cancer to target treatments that will work best. Interviews with OncLive® highlight how biomarkers are being used in colorectal and bladder cancer.
Using acitretin in combination with secukinumab resulted in nearly complete or total relief for 3 patients with severe psoriasis, according to a case study.
Intravitreal dexamethasone implants stabilized, but did not improve, vision for most patients with macular edema due to retinal vein occlusion (RVO).
May 07, 2021
A roundup of diabetes news you may have missed from across MJH Life Sciences™.
Although knowledge is plentiful on disease state improvements for adult patients with multiple sclerosis (MS) following use of newer disease-modifying therapies, less is known about similar outcomes among patients with pediatric-onset MS (POMS).
Through matching-adjusted indirect comparison, the authors of the abstract compared the use of umbralisib with other PI3Kis in this setting and found that the treatment yielded the lowest discontinuation rates due to adverse events (AEs), had a lower AE management cost burden, and achieved better duration of responses.
Specific factors, such as experience with technology and health literacy, were key drivers of whether a patient with chronic obstructive pulmonary disease (COPD) would benefit or be likely to use eHealth tools to improve self-management skills, investigators concluded.
About 90% of patients are diagnosed with rheumatoid arthritis in an outpatient setting, while the 10% diagnosed in an emergency department or as inpatients incur significantly higher health care costs.
William Shrank, MD, MSHS, the chief medical officer of Humana, discusses how the company is trying to overcome any vaccine hesitancy both in its workforce and in its insured member population.